wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37634329-0C4810A1-6B59-4970-8F1B-955284332546
Q37634329-0C4810A1-6B59-4970-8F1B-955284332546
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37634329-0C4810A1-6B59-4970-8F1B-955284332546
Omalizumab in an allergology clinic: real life experience and future developments.
P2860
Q37634329-0C4810A1-6B59-4970-8F1B-955284332546
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37634329-0C4810A1-6B59-4970-8F1B-955284332546
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0a1363a4c38cb28d98884fd10c387a7c5ccaf724
P2860
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.